Dengue Vaccines Market Expected to cross US$ 1 Billion by The End of 2031
The global dengue vaccines market is poised to expand at a staggering double-digit CAGR through 2031, surpassing US$ 1 billion during the forecast period, concludes ESOMAR-certified market research company Future Market Insights (FMI) in its recently published report.Growth is majorly underpinned by the rising incid...
New York United States United Arab Emirates Sanofi Pasteur Dengvaxia Geneone Life Science Inc Glaxosmithkline Plc
Source: pharmiweb.com